Concepedia

Ernie Harpur

EH

10

Publications

1.3K

Citations

10

H-Index

1991

Active since

Affiliations

Sanofi (United States)(Current)

Pfizer (United States)

Health and Environmental Sciences Institute

Sanofi (France)

AstraZeneca (United Kingdom)

Ernie Harpur is an author at Sanofi (United States) specializing in medicine, pharmacology, and urology.

Top concepts

Publications per year

1991–2014

10

Publications

10

A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity

Lutz Müller, Robert J. Mauthe, Christopher M. Riley et al. · Regulatory Toxicology and Pharmacology · 2006 · 454 citations

, , +10

Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium

Frank Dieterle, Frank D. Sistare, Federico Goodsaid et al. · Nature Biotechnology · 2010 · 403 citations

, , +9

Biological Qualification of Biomarkers of Chemical-Induced Renal Toxicity in Two Strains of Male Rat

Ernie Harpur, Daniela Ennulat, David Hoffman et al. · Toxicological Sciences · 2011 · 121 citations · Full text

, , +29

Towards consensus practices to qualify safety biomarkers for use in early drug development

Frank D. Sistare, Frank Dieterle, Sean P. Troth et al. · Nature Biotechnology · 2010 · 120 citations

, , +10

Evaluation of Novel Biomarkers of Nephrotoxicity in Two Strains of Rat Treated with Cisplatin

Jean‐Charles Gautier, Björn Riefke, Jakob Walter et al. · Toxicologic Pathology · 2010 · 87 citations

, , +19

Rows per page

1–5 of 10